Company: NIVFW
Filing Date: 2025-05-01
Form Type: F-1/A
Source: 0001213900-25-038045
Chunk: 105

Company: NewGenIvf Group Ltd
Filing Date: 2025-05-01
Form: F-1/A
Chunk 105
---
 charges, office supplies and staff salaries and bonus. The largest portion of clinic costs was sub-contracting charges, representing fees paid to agents who recruited surrogate mothers and assisted in the documentation, consulting and medical treatment arrangement throughout treatment procedure. NewGenIvf’s clinic costs of goods were mostly recognized during the provision of surrogacy services. Gross profit and gross margin The following table sets forth NewGenIvf’s gross profit in absolute amounts and its gross margin as percentages of total revenues, for the periods indicated.

|              |     | For the Year ended December 31, |      2024 |     |   |      |     |     |      2023 |     |   |      |
|:-------------|:----|:--------------------------------|----------:|:----|:--|-----:|:----|:----|----------:|:----|:--|-----:|
|              |     | US$                             |           |     | % |      |     | US$ |           |     | % |      |
| Gross profit |     |                                 | 1,826,894 |     |   | 33.6 |     |     | 1,681,785 |     |   | 32.7 |
| Revenues     |     |                                 | 5,433,375 |     |   |    — |     |     | 5,136,153 |     |   |    — |

NewGenIvf expects that gross profit and gross margin will continue to be affected by various factors including the geographic locations where treatments are performed, as well as the pricing with its clients, agent subcontracting charges and the costs of the supplies provided by major pharmaceutical companies, all of which are negotiated separately. 65 Operating expenses NewGenIvf’s operating expenses consist primarily of selling and marketing expenses and general and administrative expenses. NewGenIvf’s selling and marketing expenses are primarily social media expenses. NewGenIvf’s general and administrative expenses mainly include depreciation in operating lease ROU assets, and staff salaries. Other income NewGenIvf’s other income consists primarily of partial waiver of promissory note Interest expense NewGenIvf’s interest expense is incurred in relation to its interest-bearing convertible bonds. Taxation British Virgin Islands NewGenIvf is incorporated in the British Virgin Islands and is not subject to tax on income or capital gains under current British Virgin Islands law. In addition, upon payment of dividends to shareholders, no British Virgin Islands withholding tax will be imposed